Studies * EuroSIDA * Presentations * 2014

Presentations 2014

HIV Drug Therapy Glasgow 2014, 2nd-6th November 2014

Oral session No. O313: Wednesday 5th November 09.05-09.20: Predictive value of Prostate Specific Antigen for prostate cancer: a nested case control study in EuroSIDA. Presented by Leah Shepherd poster, oral presentationabstract

Oral session No. O234: Tuesday 4th November 14.45-15.00: Regional differences in self-reported HIV care and management in the EuroSIDA study. Presented by Kamilla Laut. poster,  oral presentationabstract

Poster Presentation No. P205: Wednesday 5th November 12.15-12.25: Detection of Resistance Mutations and CD4 Slopes in Individuals Experiencing Sustained Virological Failure. Presented by Anna Schultze posterabstract

Poster No. P029: The prevalence and predictive value of dipstick protein (DUP) in HIV-positive persons in Europe. Presented by Amanda Mocroft posterabstract

Poster No. P153: Plasma HIV-1 tropism and risk of short-term clinical progression to AIDS or death. Presented by Maria Casadellà Fontdevila posterabstract

Poster No. P278: Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression. Presented by Josep M Libre posterabstract

HepHIV 2014 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care

Regional differences in hepatitis testing, vaccination and treatment in the EuroSIDA study Presented by Jeff V Lazarus on behalf of EuroSIDA

21st Conference on Retroviruses and Opportunistic Infections, 3-6 March 2014, Boston

Liver-related death among HIV/HCV coinfected individuals, implications for the era of directly acting antivirals Presented by Daniel Grint on behalf of EuroSIDA